CHEMISTRY International September-October 2014 community to exploit chemical libraries and screening technologies that is not generally competitive with pharmaceutical or biotechnology research interests is in the area of orphan and neglected diseases. For example, there exist both a large research opportunity and a major unmet medical need with respect to molecules that kill persistent Mycobacterium tuberculosis (the biology of persistors is largely unknown), or molecules that target nonessential host factors that are required for viral replication (HIV, HCV, Dengue, etc.), but which will not mutate rapidly. To this end, we recently identified a molecule from a cell-based biofilm screen using Myobacterium smegmatis that kills both replicating and nonreplicating Mtb as well as XDR drug resistant strains. These molecules downregulate key mycobacterial persistence genes, and function by inhibiting two activities-the cell wall biosynthetic enzyme DprE1 and the biosynthesis of an essential molybdenum cofactor. Analogues of this compound show excellent activity in chronic models of Mtb in rodents. In addition, there are a large number of orphan diseases (type I diabetes, muscular dystrophies, spinal muscular atrophy, childhood cancers, Rett syndrome, Fragile X, Huntington disease, etc.) for which no good treatments exist. The identification of molecules that modulate these disease processes may ultimately lead to new therapies as well as provide new insight into the biology of many of these diseases.
Conclusion
Chemistry continues to evolve from its historical focus on molecular structure, reactivity, and synthesis to take on the challenge of making small and large molecules and even systems of molecules with tailored properties and functions. This requires improved theoretical and analytical tools, as well as innovative new synthetic strategies. Given the remarkable array of functions found in biological molecules, Mother Nature offers help in this regard through an approach to synthesis that seamlessly interfaces biology and chemistry. Hopefully, the examples illustrated above from our work, and the many other elegant examples in the literature, convey the exciting and highly relevant opportunities that exist for chemical synthesis at the interface of the chemical and biological sciences.
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Treasurer's Column (continued from page 2)
Even if done grudgingly a Treasurer can sometimes admit that there are other things that are as important as and perhaps even more important than money to the lifeblood of an organization. Good communications among its members and with the world at large is one of these and, in terms of general renewal, the Bureau has set as a major objective for the coming year to have a new or updated website in place by the time of the General Assembly in August of 2015. A task force, which will consult widely with the membership to establish its needs, has been established under the leadership of Bonnie Lawlor, Chair of the Committee on Publications and Cheminformatics Data Standards. This will create the vision for the website and develop informed recommendations. Every organization also needs a constant supply of new volunteers to renew and keep its business abreast of the new developments. To this end, IUPAC is streamlining the election process whereby the membership of its Divisions and Standing Committees are chosen so that we have a more transparent and effective recruitment process. Another vital necessity for success is a coherent and far-seeing strategic plan for the future and the need has been identified to draw up a contemporary strategic plan for IUPAC that will better reflect our objectives and define how these can be achieved in the modern environment. Our President, Mark Cesa, is leading a group that is formulating a new strategic plan for IUPAC for the coming years to ensure that it continues to serve the world community of chemists in both academic and commercial endeavours and continues to provide the language and standards that our subject needs to further enhance its unique and vital contribution to the progress and betterment of humankind. An IUPAC renewal is indeed very much in the air.
